Brief: Illumina Q4 Adjusted EBIT Margin 4.4%
09/01/2024 14:00
Jan 09 (Reuters) - Illumina Q4 EBIT margin -15.5%. * Q4 revenue USD 1,115 million vs. IBES estimate USD 1,068 million
Recent news on Illumina
See all newsRoche takes aim at Illumina's dominance with new gene sequencing machine (updated)
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner